121 related articles for article (PubMed ID: 6672112)
1. Comparison of the effects of alpha and beta interferons on the proliferation and volume of human tumor cells (HeLa-S3, Daudi, P3HR-1).
Pfeffer LM; Tamm I
J Interferon Res; 1983; 3(4):395-408. PubMed ID: 6672112
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.
Geng Y; Choubey D
J Biol Regul Homeost Agents; 2000; 14(4):263-8. PubMed ID: 11215814
[TBL] [Abstract][Full Text] [Related]
3. Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study.
Madsen PS; Nielsen B; Jensen AW; Justesen J; Ellegaard J; Hokland P; Hokland M
J Interferon Res; 1992 Oct; 12(5):345-53. PubMed ID: 1431314
[TBL] [Abstract][Full Text] [Related]
4. Comparative antiproliferative efficacies of human alpha and gamma interferons.
Rubin BY; Sekar V; Martimucci WA
J Gen Virol; 1983 Aug; 64 (Pt 8)():1743-8. PubMed ID: 6409992
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.
Kumar R; Atlas I
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6599-603. PubMed ID: 1631162
[TBL] [Abstract][Full Text] [Related]
6. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
Borden EC; Hogan TF; Voelkel JG
Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
Lidin B; Lamon EW
Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth.
Knight E; Fahey D; Blomstrom DC
J Interferon Res; 1985; 5(2):305-13. PubMed ID: 4009002
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
10. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
[TBL] [Abstract][Full Text] [Related]
11. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antitumor effects of human natural and recombinant interferons (alpha and beta) on human cancer cell lines.
Motoo Y; Hill NO; Osther K
Jpn J Exp Med; 1986 Feb; 56(1):13-8. PubMed ID: 3014184
[TBL] [Abstract][Full Text] [Related]
13. Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
Maloney MD; Binnington-Boyd B; Lingwood CA
Glycoconj J; 1999 Dec; 16(12):821-8. PubMed ID: 11133022
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells.
Rath PC; Aggarwal BB
J Interferon Cytokine Res; 2001 Jul; 21(7):523-8. PubMed ID: 11506747
[TBL] [Abstract][Full Text] [Related]
16. Early plasma membrane depolarization by alpha interferon: biologic correlation with antiproliferative signal.
Grimley PM; Aszalos A
Biochem Biophys Res Commun; 1987 Jul; 146(1):300-6. PubMed ID: 3606620
[TBL] [Abstract][Full Text] [Related]
17. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
[TBL] [Abstract][Full Text] [Related]
18. Presence of an abnormal beta 2-microglobulin mRNA in Daudi cells: induction by interferon.
Rosa F; Fellous M; Dron M; Tovey M; Revel M
Immunogenetics; 1983; 17(2):125-31. PubMed ID: 6186603
[TBL] [Abstract][Full Text] [Related]
19. Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines.
Milner AE; Grand RJ; Gregory CD
Int J Cancer; 1995 May; 61(3):348-54. PubMed ID: 7729947
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory and antiproliferative effect of recombinant alpha, beta, and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271.
Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB
J Invest Dermatol; 1985 Jun; 84(6):487-90. PubMed ID: 3923127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
